Future work should elucidate the importance of IGFBP4 in this hypoxia-induced pathway and investigate if modulating hepatic IGFBP4 synthesis could relieve some of the negative consequences associated with OSA. The gene discussed is IGFBP4; the disease is obstructive sleep apnea syndrome.